Blog

New immunotherapy combination shows promise for patients with advanced melanoma – Medical Xpress

New immunotherapy combination shows promise for patients with advanced melanoma
Medical Xpress
Treatment with a combination of ipilimumab (Yervoy) and Coxsackievirus A21 (CVA21; Cavatak) led to durable responses in a number of patients with advanced melanoma, including some whose melanoma had progressed despite prior treatment with an …

2017-04-05 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.